ArticleScience advances2022

Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease.

Xian-Le Bu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.